未找到相关数据
Impact of CBM588 on gut microbiome composition and dysbiosis in patients receiving frontline immune checkpoint inhibitor (ICI) combinations for metastatic renal cell carcinoma (mRCC)
被引：0
作者：
Dizman, Nazli
Ebrahimi, Hedyeh
Carrillo, Regina Barragan
Meza, Luis A.
Bergerot, Paulo Gustavo
Dorff, Tanya B.
Hsu, Joann
Zengin, Zeynep Busra
Castro, Daniela V.
Chehrazi-Raffle, Alex
Tripathi, Abhishek
Trent, Jeffrey M.
Takahashi, Motomichi
Oka, Kentaro
Higashi, Seiya
Caporaso, Gregory
Lee, Keehoon
Pal, Sumanta Kumar
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] City Hope Comprehens Canc Ctr, Duarte, CA USA
[3] Oncoclin & Co, Med Sci Innovat Res MEDSIR, Sao Paulo, Brazil
[4] City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA USA
[5] TGen, Phoenix, AZ USA
[6] Miyarisan Pharmaceut Co Ltd, Saitama, Japan
[7] Translat Genom Inst, Phoenix, AZ USA
[8] Translat Genom Res Inst TGen North, Flagstaff, AZ USA
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4550
引用
收藏
页数：1
相关论文